Protagonist Therapeutics | 8-K: Current report
Protagonist Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ali Asif
Protagonist Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Waddill William D.
Protagonist Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Protagonist Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Protagonist Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(18.2%)
Protagonist Therapeutics | 10-Q: Q2 2024 Earnings Report
Protagonist Therapeutics | 8-K: Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Protagonist Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Waddill William D.
Protagonist Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Protagonist Therapeutics | 8-K: Current report
Protagonist Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer PATEL DINESH V PH D
Protagonist Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer PATEL DINESH V PH D
Protagonist Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Waddill William D.
Protagonist Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Protagonist Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Protagonist Therapeutics | 10-Q: Q1 2024 Earnings Report
Protagonist Therapeutics | 8-K: Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Protagonist Therapeutics | ARS: Annual Report to Security Holders
Protagonist Therapeutics | DEFA14A: Others
No Data
No Data